Welcome to the working week, although this will be a shortened one due to the pending holiday. Nonetheless, the usual routine is in full swing, which means we are brewing the mandatory cup of stimulation and poking about for interesting items. Let us know if you hear of anything. Meanwhile, here are a few tidbits. Hope your day goes well...
Gilead To Buy Arresto Biosciences For $225M (Bloomberg News)
Gunmen Raid Distribution Facility But Are Apprehended (Securing Pharma)
Genzyme To Push Argument For Campath Value (Reuters)
Novartis To Invest $500M In Russia And Build Plant (Bloomberg News)
Sanofi-Aventis And Avila Sign Cancer Drug Deal (Reuters)
Claris Promises To Resolve FDA Problems Soon (MoneyControl)
Phylogica And Pfizer Sign Vaccines Deal (Sydney Morning Herald)
Another Prempro Trial Is About To Begin (Reno Gazette-Journal)
WikiLeaks Cable Discloses Pricing Posturing (New Zealand Herald)